A variety of conventional chemotherapies induce immunogenic cell death (ICD) in tumor cells, which is characterized by translocation of calreticulin to the cell surface and release of damage-associated molecular pattern (DAMP) molecules to recruit and activate antigen-presenting cells including DCs and M1-TAMs [34]. Here, CALR is linked to neoplasm.